Literature DB >> 11246874

Distinction between interleukin-1-induced necrosis and apoptosis of islet cells.

A Hoorens1, G Stangé, D Pavlovic, D Pipeleers.   

Abstract

Interleukin (IL)-1beta is known to cause beta-cell death in isolated rat islets. This effect has been attributed to induction of nitric oxide (NO) synthase in beta-cells and subsequent generation of toxic NO levels; it was not observed, however, in dispersed rat beta-cells. The present study demonstrates that IL-1beta induces NO-dependent necrosis in rat beta-cells cultured for 3 days at high cell density or in cell aggregates but not as single cells. Its cytotoxic condition is not explained by higher NO production rates but might result from higher intercellular NO concentrations in statically cultured cell preparations with cell-to-cell contacts; nitrite levels in collected culture medium are not a reliable index for these intercellular concentrations. Absence of IL-1-induced necrosis in rat alpha-cells or in human beta-cells is attributed to the cytokine's failure to generate NO in these preparations, not to their reduced sensitivity to NO: the NO donor GEA 3162 (15 min, 50-100 micromol/l) exerts a comparable necrotic effect in rat and human alpha- or beta-cells. In preparations in which IL-1beta does not cause beta-cell necrosis, its combination with gamma-interferon (IFN-gamma) results in NO-independent apoptosis, starting after 3 days and increasing with the duration of exposure. Because IFN-gamma alone was apoptotic for rat alpha-cells, it is proposed that IL-1beta can make beta-cells susceptible to this effect, conceivably through altering their phenotype. It is concluded that IL-1beta can cause NO-dependent necrosis or NO-independent apoptosis of islet cells, depending on the species and on the environmental conditions. The experiments in isolated human beta-cell preparations suggest that these cells may preferentially undergo apoptosis when exposed to IL-1beta plus IFN-gamma unless neighboring non-beta-cells produce toxic NO levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246874     DOI: 10.2337/diabetes.50.3.551

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets.

Authors:  P Ylipaasto; B Kutlu; S Rasilainen; J Rasschaert; K Salmela; H Teerijoki; O Korsgren; R Lahesmaa; T Hovi; D L Eizirik; T Otonkoski; M Roivainen
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

3.  Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.

Authors:  R Eldor; A Yeffet; K Baum; V Doviner; D Amar; Y Ben-Neriah; G Christofori; A Peled; J C Carel; C Boitard; T Klein; P Serup; D L Eizirik; D Melloul
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-21       Impact factor: 11.205

4.  Donor Pretreatment With IL-1 Receptor Antagonist Attenuates Inflammation and Improves Functional Potency in Islets From Brain-Dead Nonhuman Primates.

Authors:  Juan S Danobeitia; Matthew S Hanson; Peter Chlebeck; Elisa Park; Jamie M Sperger; Alice Schwarznau; Luis A Fernandez
Journal:  Cell Transplant       Date:  2014-04-22       Impact factor: 4.064

5.  Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.

Authors:  M N Pham; M I Hawa; C Pfleger; M Roden; G Schernthaner; P Pozzilli; R Buzzetti; W A Scherbaum; W Scherbaum; J Seissler; H Kolb; S Hunter; R D G Leslie; N C Schloot
Journal:  Diabetologia       Date:  2011-02-24       Impact factor: 10.122

6.  Connexins protect mouse pancreatic β cells against apoptosis.

Authors:  Philippe Klee; Florent Allagnat; Helena Pontes; Manon Cederroth; Anne Charollais; Dorothée Caille; Aurore Britan; Jacques-Antoine Haefliger; Paolo Meda
Journal:  J Clin Invest       Date:  2011-11-07       Impact factor: 14.808

7.  CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines.

Authors:  O Vosters; C Beuneu; N Nagy; B Movahedi; E Aksoy; I Salmon; D Pipeleers; M Goldman; V Verhasselt
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

8.  Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans.

Authors:  Reid Aikin; Lawrence Rosenberg; Steven Paraskevas; Dusica Maysinger
Journal:  J Mol Med (Berl)       Date:  2004-04-23       Impact factor: 4.599

9.  Suppressor of cytokine signaling-1 inhibits caspase activation and protects from cytokine-induced beta cell death.

Authors:  Irina I Zaitseva; Monica Hultcrantz; Vladimir Sharoyko; Malin Flodström-Tullberg; Sergei V Zaitsev; Per-Olof Berggren
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

10.  Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1.

Authors:  I Rakatzi; H Mueller; O Ritzeler; N Tennagels; J Eckel
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.